214.04
전일 마감가:
$212.66
열려 있는:
$215.05
하루 거래량:
4.69M
Relative Volume:
0.76
시가총액:
$337.60B
수익:
$123.70B
순이익/손실:
$18.29B
주가수익비율:
19.39
EPS:
11.0411
순현금흐름:
$39.02B
1주 성능:
+1.00%
1개월 성능:
+11.55%
6개월 성능:
+19.97%
1년 성능:
+62.25%
모건 스탠리 Stock (MS) Company Profile
명칭
Morgan Stanley
전화
212-761-4000
주소
1585 BROADWAY, NEW YORK, NY
Compare MS vs GS, SCHW, HOOD, IBKR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
MS
Morgan Stanley
|
214.04 | 335.43B | 123.70B | 18.29B | 39.02B | 11.04 |
|
GS
Goldman Sachs Group Inc
|
1,062.75 | 305.52B | 129.01B | 18.07B | 112.72B | 54.72 |
|
SCHW
Charles Schwab Corp
|
91.10 | 154.26B | 28.33B | 9.42B | 9.76B | 5.0426 |
|
HOOD
Robinhood Markets Inc
|
93.19 | 83.05B | 4.65B | 1.89B | -2.09B | 2.0676 |
|
IBKR
Interactive Brokers Group Inc
|
90.81 | 39.57B | 10.76B | 4.56B | 35.82B | 2.326 |
모건 스탠리 Stock (MS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-27 | 업그레이드 | Erste Group | Hold → Buy |
| 2026-04-07 | 업그레이드 | UBS | Neutral → Buy |
| 2026-03-05 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-11-24 | 업그레이드 | Wolfe Research | Peer Perform → Outperform |
| 2025-10-03 | 개시 | BMO Capital Markets | Outperform |
| 2025-07-09 | 업그레이드 | Keefe Bruyette | Mkt Perform → Outperform |
| 2024-11-26 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2024-11-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2024-10-04 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2024-09-11 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-08-02 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2024-07-17 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-01-17 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-01-17 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2024-01-09 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2023-11-28 | 다운그레이드 | Societe Generale | Buy → Hold |
| 2023-11-20 | 다운그레이드 | Exane BNP Paribas | Outperform → Neutral |
| 2023-10-23 | 다운그레이드 | Odeon | Buy → Hold |
| 2023-10-20 | 업그레이드 | Wolfe Research | Underperform → Peer Perform |
| 2023-10-11 | 다운그레이드 | UBS | Buy → Neutral |
| 2023-09-07 | 개시 | HSBC Securities | Buy |
| 2023-07-12 | 업그레이드 | Odeon | Hold → Buy |
| 2023-01-18 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-01-10 | 업그레이드 | Odeon | Sell → Hold |
| 2023-01-04 | 다운그레이드 | Wolfe Research | Outperform → Underperform |
| 2022-10-05 | 다운그레이드 | Atlantic Equities | Overweight → Neutral |
| 2022-09-06 | 다운그레이드 | Odeon | Hold → Sell |
| 2022-05-03 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2022-01-28 | 다운그레이드 | Odeon | Buy → Hold |
| 2021-12-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2021-10-15 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-10-04 | 재확인 | Jefferies | Buy |
| 2021-09-29 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-09-28 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-08-13 | 다운그레이드 | Seaport Global Securities | Buy → Neutral |
| 2021-07-07 | 재개 | Keefe Bruyette | Outperform |
| 2021-06-09 | 개시 | Jefferies | Buy |
| 2021-04-21 | 업그레이드 | Berenberg | Hold → Buy |
| 2021-03-02 | 업그레이드 | Daiwa Securities | Neutral → Outperform |
| 2021-01-06 | 개시 | Daiwa Securities | Neutral |
| 2021-01-04 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2020-11-10 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-10-13 | 재개 | JP Morgan | Overweight |
| 2020-07-08 | 개시 | Seaport Global Securities | Buy |
| 2020-06-24 | 업그레이드 | DA Davidson | Neutral → Buy |
| 2020-06-23 | 재확인 | UBS | Buy |
| 2020-05-21 | 업그레이드 | Odeon | Hold → Buy |
| 2020-04-14 | 업그레이드 | Societe Generale | Sell → Buy |
| 2020-03-13 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-04 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-02-21 | 다운그레이드 | DA Davidson | Buy → Neutral |
| 2020-02-20 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-01-21 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2020-01-17 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-01-13 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2020-01-09 | 개시 | DA Davidson | Buy |
| 2020-01-06 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2019-10-29 | 다운그레이드 | Odeon | Buy → Hold |
| 2019-10-10 | 업그레이드 | Sandler O'Neill | Hold → Buy |
| 2019-07-12 | 업그레이드 | Citigroup | Neutral → Buy |
| 2019-04-18 | 다운그레이드 | Citigroup | Buy → Neutral |
모두보기
모건 스탠리 주식(MS)의 최신 뉴스
Enliven Therapeutics Prices ~$376 Million Equity Offering; Jefferies, Goldman, Morgan Stanley Lead - TradingView
Broker files Form 144 for AMBA: scheduled restricted stock vesting events (AMBA) - Stock Titan
Morgan Stanley lists sale of 5,500 Teekay units (TK) in Form 144/A - Stock Titan
PSX Maintained by Morgan Stanley -- Price Target Raised to $196 - GuruFocus
VLO Maintained by Morgan Stanley -- Price Target Raised to $255 - GuruFocus
Morgan Stanley sends clear message on eBay, Etsy - Yahoo Finance Singapore
Here’s What a $1,000 Investment in SpaceX’s IPO Would Be Worth Today — and What Could Come Next - The Motley Fool
MPC Maintained by Morgan Stanley -- Price Target Raised to $265 - GuruFocus
DK Maintained by Morgan Stanley -- Price Target Raised to $45 - GuruFocus
Explainer: SpaceX's IPO includes a "greenshoe" option – here's what that means - Reuters
Morgan Stanley (MS) offers 22% auto-callable notes on CoreWeave stock - Stock Titan
Rockefeller, Stifel Add From Morgan Stanley in North Carolina, Illinois - AdvisorHub
Morgan Stanley (MS-PA) offers 3‑year auto‑call notes paying 33.58% coupon - Stock Titan
[424B2] MORGAN STANLEY Prospectus Supplement - Stock Titan
Goldman and Morgan Stanley to Pocket $100 Million Each In SpaceX IPO Fees - WSJ
Morgan Stanley (MS) issues dual‑underlier note tied to LLY and NVO with 35% buffer - Stock Titan
Healthpeak Properties (DOC) Downgraded by Morgan Stanley Amid Ma - GuruFocus
Morgan Stanley (NYSE: MS) sells 12.5% contingent auto-call notes tied to FIVE - Stock Titan
Morgan Stanley (MS) launches 10.75% contingent coupon auto‑callable notes due 2031 - Stock Titan
Morgan Stanley (MS) offers principal-at-risk notes; auto-call June 2027, 248% participation - Stock Titan
Morgan Stanley (MS) sells $1,000 auto‑callable notes, 9.05% coupon, worst‑of indices - Stock Titan
Morgan Stanley (MS) launches 5‑year auto‑callable notes — 9.65% coupon, principal at risk - Stock Titan
Morgan Stanley Calls Meta Platforms (NASDAQ: META) A Top Mega-Cap Pick With $775 Price Target - foreignpolicyjournal.com
Morgan Stanley (MS) sells Trigger PLUS notes maturing June 13, 2031 with 530% leverage - Stock Titan
Morgan Stanley (MS) sells $24.7M contingent‑income, principal‑at‑risk notes - Stock Titan
Morgan Stanley (MS) offers 9% contingent-income auto-callable notes due Dec 2030 - Stock Titan
Morgan Stanley (MS) sells Trigger PLUS: 175% upside vs. worst-performing index - Stock Titan
Morgan Stanley (MS) issues S&P 500 buffered notes, 100% participation - Stock Titan
Morgan Stanley (MS) offers $1,000 auto-callable notes linked to Nasdaq‑100, Russell 2000, S&P 500 - Stock Titan
Morgan Stanley (MS) issues callable principal‑at‑risk notes paying 9.55% contingent coupon - Stock Titan
Morgan Stanley Nearing 52-Week High: Buy, Sell or Hold? - 24/7 Wall St.
Morgan Stanley (NYSE: MS) offers Buffered PLUS notes — 30% buffer, 120% leverage - Stock Titan
Morgan Stanley (MS) launches S&P 500 buffered participation notes, cap $1,195 - Stock Titan
Morgan Stanley (MS) offers $1M Structured Notes linked to RBRK and VEEV - Stock Titan
Morgan Stanley resets staggering Chewy stock target - thestreet.com
Morgan Stanley, Nomura Raise KOSPI Targets Toward 10,000 Range - Businesskorea
How Investors May Respond To Morgan Stanley (MS) Opening Stock-Plan Platforms To External AI Agents - Yahoo Finance
Morgan Stanley (MS) offers Dual Directional Buffered PLUS linked to SX5E and SPX - Stock Titan
Morgan Stanley Institutional Consulting Solutions Archives - Alternative Credit Investor
Principal‑at‑risk notes from Morgan Stanley (MS) tied to SX5E, RTY, XLP - Stock Titan
Morgan Stanley (MS) issues auto‑call notes paying 13.40% contingent coupon - Stock Titan
Morgan Stanley (MS) offers $2.5M callable notes with 17.75% contingent coupon - Stock Titan
Morgan Stanley Keeps M&A Door Open Amid $10T Wealth Push - The Globe and Mail
Morgan Stanley updates jaw-dropping Carvana stock price target - thestreet.com
Morgan Stanley Downgrades Healthpeak, Alexandria on Uncertain Lab Market Recovery - citybiz
Morgan Stanley downgrades two life sciences REITs over limited visibility on lab market recovery (ARE:NYSE) - Seeking Alpha
CSCO Maintained by Morgan Stanley -- Price Target Raised to $130 - GuruFocus
Balance of Fed policy risks shifting to firmer inflation, Morgan Stanley says - Investing.com
Humiliating Elon Musk Inflatable Appears Out of Nowhere - The Daily Beast
Morgan Stanley Maintains TransUnion(TRU.US) With Buy Rating, Maintains Target Price $100 - 富途牛牛
Alts now largest allocation in non-profits’ portfolios ahead of US equities - Alternative Credit Investor
모건 스탠리 (MS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):